The T2 Mycobacterium tuberculosis genotype, predominant in Kampala, Uganda, shows negative correlation with antituberculosis drug resistance

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 7, 2014, Pages 3853-3859

  Lukoye, Deus ^a   Katabazi, Fred A ^b   Musisi, Kenneth ^c   Kateete, David P ^b   Asiimwe, Benon B ^b   Okee, Moses ^b   Joloba, Moses L ^b,c   Cobelens, Frank G J ^d,e  

^a Ugandan National Tuberculosis and Leprosy Programme   (Uganda)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c National Tuberculosis Reference Laboratory   (Uganda)

^d AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^e KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENOTYPE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECIES DISTRIBUTION; SPUTUM CULTURE; SPUTUM SMEAR; STRUCTURED INTERVIEW; UGANDA; ADOLESCENT; COMPLICATION; DRUG EFFECTS; GENETICS; HEALTH SURVEY; HIV INFECTIONS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; SERODIAGNOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PUBLIC HEALTH SURVEILLANCE; TUBERCULOSIS, MULTIDRUG-RESISTANT; UGANDA; YOUNG ADULT;

EID: 84903132537     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02338-13     Document Type: Article

References (30)

1. Burgos MV, Pym AS. 2002. Molecular epidemiology of tuberculosis. Eur. Respir. J. Suppl. 36:54S-65S. http://dx.doi.org/10.1183/09031936.02.00400702. (Pubitemid 34774188)
2. Allix-Beguec C, Harmsen D, Weniger T, Supply P, Niemann S. 2008. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 46:2692-2699. http://dx.doi.org/10.1128/JCM.00540-08.
3. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914. (Pubitemid 27146535)
4. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
5. Cox HS, Kubica T, Doshetov D, Kebede Y, Rusch-Gerdess S, Niemann S. 2005. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia. Respir. Res. 6:134. http://dx.doi.org/10.1186/1465-9921-6-134.
6. Kubica T, Agzamova R, Wright A, Aziz MA, Rakishev G, Bismilda V, Richter E, Rusch-Gerdes S, Niemann S. 2005. The Beijing genotype is a major cause of drug-resistant tuberculosis in Kazakhstan. Int. J. Tuberc. Lung Dis. 9:646-653. (Pubitemid 40826157)
7. Sheen P, Couvin D, Grandjean L, Zimic M, Dominguez M, Luna G, Gilman RH, Rastogi N, Moore DA. 2013. Genetic diversity of Mycobacterium tuberculosis in Peru and exploration of phylogenetic associations with drug resistance. PLoS One 8:e65873. http://dx.doi.org/10.1371/journal.pone.0065873.
8. Dye C, Williams BG, Espinal MA, Raviglione MC. 2002. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 295:2042-2046. http://dx.doi.org/10.1126/science.1063814. (Pubitemid 34229458)
9. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB. 2009. Tuberculosis drug resistance mutation database. PLoS Med. 6:e2. http://dx.doi.org/10.1371/journal.pmed.1000002.
10. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis. 8:843-849. http://dx.doi.org/10.3201/ eid0808.020002.
11. Johnson R, Warren RM, van der Spuy GD, Gey van Pittius NC, Theron D, Streicher EM, Bosman M, Coetzee GJ, van Helden PD, Victor TC. 2010. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int. J. Tuberc. Lung Dis. 14:119-121.
12. WHO. 2012. Global tuberculosis control. WHO, Geneva, Switzerland.
13. Lukoye D, Adatu F, Musisi K, Kasule GW, Were W, Odeke R, Kalamya JN, Awor A, Date A, Joloba ML. 2013. Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey. PLoS One 8:e70763. http://dx.doi.org/10. 1371/journal.pone.0070763.
14. Uganda Ministry of Health. 2011. Uganda AIDS indicator survey. Ministry of Health, Kampala, Uganda.
15. Kampala Capital City Authority. 2011. Kampala district profile. Kampala Capital City Authority, Kampala, Uganda.
16. Lukoye D, Cobelens FG, Ezati N, Kirimunda S, Adatu FE, Lule JK, Nuwaha F, Joloba ML. 2011. Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection. PLoS One 6:e16130. http://dx.doi.org/10.1371/journal.pone.0016130.
17. Asiimwe BB, Ghebremichael S, Kallenius G, Koivula T, Joloba ML. 2008. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, Uganda. BMC Infect. Dis. 8:101. http://dx.doi.org/10.1186/1471-2334-8-101.
18. Bazira J, Asiimwe BB, Joloba ML, Bwanga F, Matee MI. 2011. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda. BMC Infect. Dis. 11:81. http://dx.doi.org/10.1186/1471-2334-11-81.
19. Muwonge A, Malama S, Johansen TB, Kankya C, Biffa D, Ssengooba W, Godfroid J, Djonne B, Skjerve E. 2013. Molecular epidemiology, drug susceptibility and economic aspects of tuberculosis in Mubende district, Uganda. PLoS One 8:e64745. http://dx.doi.org/10.1371/journal.pone.0064745.
20. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM, Small PM. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409. (Pubitemid 23028649)
21. Muhumuza J, Asiimwe BB, Kayes S, Mugyenyi R, Whalen C, Mugerwa RD, Boom H, Eisenach KD, Joloba ML. 2006. Introduction of an inhouse PCR for routine identification of M. tuberculosis in a low-income country. Int. J. Tuberc. Lung Dis. 10:1262-1267. (Pubitemid 44713481)
22. Huard RC, Fabre M, de Haas P, Lazzarini LC, van Soolingen D, Cousins D, Ho JL. 2006. Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex. J. Bacteriol. 188:4271-4287. http://dx.doi.org/10.1128/JB.01783-05. (Pubitemid 43865747)
23. Shabbeer A, Cowan LS, Ozcaglar C, Rastogi N, Vandenberg SL, Yener B, Bennett KP. 2012. TB-Lineage: an online tool for classification and analysis of strains of Mycobacterium tuberculosis complex. Infect. Genet. Evol. 12:789-797. http://dx.doi.org/10.1016/j.meegid.2012.02.010.
24. Niemann S, Rusch-Gerdes S, Joloba ML, Whalen CC, Guwatudde D, Ellner JJ, Eisenach K, Fumokong N, Johnson JL, Aisu T, Mugerwa RD, Okwera A, Schwander SK. 2002. Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J. Clin. Microbiol. 40:3398-3405. http://dx.doi.org/10.1128/JCM.40.9.3398-3405. 2002. (Pubitemid 34977459)
25. Niemann S, Diel R, Khechinashvili G, Gegia M, Mdivani N, Tang YW. 2010. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia. J. Clin. Microbiol. 48:3544-3550. http://dx.doi.org/10.1128/JCM.00715-10.
26. Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, Raviglione M. 2012. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull. World Health Organ. 90:111D-119D. http://dx.doi.org/10.2471/BLT.11.092585.
27. Rieder H. 2005. Annual risk of infection with Mycobacterium tuberculosis. Eur. Respir. J. 25:181-185. http://dx.doi.org/10.1183/09031936.04.00103804. (Pubitemid 40207748)
28. Middelkoop K, Bekker LG, Mathema B, Shashkina E, Kurepina N, Whitelaw A, Fallows D, Morrow C, Kreiswirth B, Kaplan G, Wood R. 2009. Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J. Infect. Dis. 200:1207-1211. http://dx.doi.org/10.1086/ 605930.
29. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuno L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de Viedma D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, Kulkarni SP, Liens B, Lillebaek T, Ho ML, Martin C, Martin C, Mokrousov I, Narvskaia O, Ngeow YF, Naumann L, Niemann S, Parwati I, Rahim Z, Rasolofo-Razanamparany V, Rasolonavalona T, Rossetti ML, Rusch-Gerdes S, Sajduda A, Samper S, Shemyakin IG, Singh UB, Somoskovi A, Skuce RA, van Soolingen D, Streicher EM, Suffys PN, Tortoli E, Tracevska T, Vincent V, Victor TC, Warren RM, Yap SF, Zaman K, Portaels F, Rastogi N, Sola C. 2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 6:23. http://dx.doi.org/10.1186/1471-2180-6-23.
30. Ogaro TD, Githui W, Kikuvi G, Okari J, Asiko V, Wangui E, Jordaan AM, Van Helden PD, Streicher ME, Victor TC. 2012. Diversity of Mycobacterium tuberculosis strains in Nairobi, Kenya. Afr. J. Health Sci. 20:82-90.